We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APYX icon
976
Apyx Medical
APYX
$171M
$427K 0.01%
163,100
ATNM icon
977
Actinium Pharmaceuticals
ATNM
$25M
$427K 0.01%
83,966
+20,000
+31% +$103K
PYXS icon
978
Pyxis Oncology
PYXS
$236M
$425K 0.01%
236,195
UPLD icon
979
Upland Software
UPLD
$15.4M
$424K 0.01%
10,030
LBPH
980
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$422K 0.01%
70,000
+20,000
+40% +$99.7K
BDSX icon
981
Biodesix
BDSX
$248M
$422K 0.01%
11,460
+2,460
+27% +$77.2K
REKR icon
982
Rekor Systems
REKR
$91.7M
$421K 0.01%
+126,400
New +$360K
KVHI icon
983
KVH Industries
KVHI
$157M
$419K 0.01%
79,704
+1,920
+2% +$9.38K
BRN icon
984
Barnwell Industries
BRN
$14.1M
$417K 0.01%
171,553
+3,648
+2% +$9.08K
XTNT icon
985
Xtant Medical Holdings
XTNT
$62.3M
$416K 0.01%
368,500
+200,000
+119% +$235K
FFWM
986
DELISTED
First Foundation Inc
FFWM
$415K 0.01%
42,880
+3,840
+10% +$24.5K
TSVT
987
DELISTED
2seventy bio
TSVT
$413K 0.01%
+96,700
New +$297K
VABK icon
988
Virginia National Bankshares
VABK
$260M
$409K 0.01%
11,895
-1,200
-9% -$39.4K
CVM icon
989
CEL-SCI Corp
CVM
$30.1M
$408K 0.01%
4,997
WOW
990
DELISTED
WideOpenWest
WOW
$407K 0.01%
+100,600
New +$541K
TZOO icon
991
Travelzoo
TZOO
$75.4M
$406K 0.01%
42,643
NATH icon
992
Nathan's Famous
NATH
$402M
$406K 0.01%
5,200
LOOP icon
993
Loop Industries
LOOP
$32.9M
$406K 0.01%
107,300
+7,900
+8% +$27.6K
GBIO
994
DELISTED
Generation Bio
GBIO
$401K 0.01%
+24,300
New +$424K
IPSC icon
995
Century Therapeutics
IPSC
$361M
$399K 0.01%
120,100
-44,900
-27% -$81.8K
TRAK icon
996
ReposiTrak
TRAK
$159M
$397K 0.01%
39,627
+11,900
+43% +$117K
GRTS
997
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$396K 0.01%
193,900
BYRN icon
998
Byrna Technologies
BYRN
$101M
$395K 0.01%
61,771
IVAC
999
DELISTED
Intevac Inc
IVAC
$392K 0.01%
90,700
RCEL icon
1000
Avita Medical
RCEL
$240M
$391K 0.01%
28,518

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.